 

FINAL DIAGNOSIS:

PART 1: RIGHT URETER. DISTAL, SHAVE MARGIN. BIOPSY-

A. BENIGN URETER.
B. NEGATIVE FOR NEOPLASIA.

A. BENIGN URETER.
B. NEGATIVE FOR NEOPLASIA.

I
PART 2: LEFT, URETER. DISTAL. SHAVE MARGIN, BIOPSY- IIII

UUID: 8716FE32- MDD- AEFF- BlAG- D679A5C75C7eGd
TCGA— BT- A42C- 01A- PR

IIIIIIIlIIlIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIeIIIIIIIIIeaI
IlIIIIIIIIlIIIIIIIIIIIIIIIIIIIIIIIIIII
I lIIIIllIIIIIIIIIIIIIIIIIIIII|IIllIIIIIIIIIIIIIIIIIIIIIIIII

PART 3: URINARY BLADDER, DISTAL URETERS, PROSTATE, BILATERAL SEMINAL VESICLES, AND BILATERAL DISTAL

VASA DEF ERENTIA RADICAL CYSTOPROSTATECTOMY -

A. INVASIVE UROTHELIAL CARCINOMA, HIGH-GRADE (2004 WHOIISUP) (SLIDES 3E. 3F 3L. SR, 38, ST, 3U. 3V),
ASSOCIATED WITH FOCAL HIGH-GRADE PAPILLARY UROTHELIAL CARCINOMA (SLIDES 3H, 30, 33). TUMOR
MEASURES 3.5 x 1.5 x 0.4 CM, AND IS PRESENT IN THE LEFT LATERAL WALL AND TRIGONE. CARCINOMA
INFILTRATES INTO THE SUPERFICIAL DETRUSOR MUSCLE (INNER HALF).

.

TNM PATHOLOGIC STAGE: pTZa N0 MX (SEE SYNOPTIC).
BIOPSY SITE CHANGES.

9 moon 9

UROTHELIAL DYSPLASIA THROUGH CARCINOMA IN SITU IS PRESENT IN THE RIGHT URETERAL OSTIUM
(SLIDE 3G), LEFT URETERAL OSTIUM (SLIDE 3H). AND ANTERIOR WALL] DOME (SLIDE 3N).

NO DEFINITIVE ANGIOLYMPHATIC INVASION IS IDENTIFIED (SLIDE 3E).

ALL EXAMINED SURGICAL RESECTION MARGINS ARE FREE OF UROTHELIAL NEOPLASIA.

BACKGROUND BLADDER WITH GRANULOMATOUS INFLAMMATION (HISTORY OF 306 THERAPY) AND
BENIGN PROSTATE WITH MULTIFOCAL NECROTIZING GRANULOMAS (HISTORY OF BCG THERAPY),

NODULAR HYPERPLASIA, FOCAL GLANDULAR ATROPHY. AND CHRONIC INFLAMMATION.

H. BENIGN BILATERAL SEMINAL VESICLES.
PART 4: LYMPH NODES, RIGHT PELVIC. EXCISION

A. ND EVIDENCE OF MALIGNANCY IN SEVENTEEN LYMPH NODES (0I17).
B. ONE LYMPH NODE WITH FEW NON-NECROTIZING GRANULOMAS (SLIDE 43).

PART 5: LYMPH NODES, LEFT PELVIC. EXCISION
A. ND EVIDENCE OF NEOPLASIA IN SIX LYMPH NODES (DIS).

B. ONE LYMPH NODE WITH A SMALL NON-NECROTIZING GRANULOMA (SLIDE 4K}.

CASE SYNOPSIS:
SYNOPTIC DATA - PRIMARY URINARY BLADDER TUMORS

SPECIMEN TYPE: Radical cystoprostatectomy

TUMOR SITE: Trlgone, Left lateral wall

TUMOR SIZE: Greatest dimenslon: 3.5 cm
Additional dimensions: 1.5 x 0.4 cm

HISTOLOGIC TYPE: Urothelial (transitional cell) carcinoma

ASSOCIATED EPITHELIAL LESIONS:

None identiﬁed

HISTOLOGIC GRADE: Urotheiiai carcinoma - High-grade
TUMOR CONFIGURATION: Papillary, Flat. Ulcerated
PATHOLOGIC STAGING (pTNM): pT2a

pNO

MARGINS:

Number of nodes examined: 23
Number of nodes involved: 0
pMX
Margins uninvolved by invasive carcinoma
Margin(s) uninvolved by carcinoma in situ

VENOUSILYMPHATIC (LARGEISMALLI VESSEL INVASION (VIL):

DIRECT EXTENSION OF INVASIVE TUMOR: None identiﬁed

ADDITIONAL PATHOLOGIC FINDINGS:
Therapy-related changes

(CD’O’3

M(OWII',QI Carcinoma. Tnpiliar)
@3013
Si-Ic'

Mmbiacide/ N03
(30% I ccnq

CQCR Madden wall, IOIIWOJ

CLOIZ
QT!" 2 £0

Wr r.“
Diagnosis DIsuenancv

Absent

Urolheiial carcinoma in situ

     
 

Frlmar Tumor S‘Itp Discre - arcy

HIPAA Discrepancy
PrIor Malignancy III: tor;

puai,'5vn=h'°"°”‘F'ma/W'wr' I u -UA 5'

Case I: (circ lie) “we" ’
Reviewer lnitIals_ —we ke

  
 
  
    
    

 

